Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 19, 2025 07:30 ET | Source: FACT.MR

Image-Guided Surgery (IGS) Devices Market to Reach USD 21.39 Billion by 2035, Growing at 8.7% CAGR | Fact.MR Report

Rockville, MD, March 19, 2025 (GLOBE NEWSWIRE) -- According to Fact.MR, a market research and competitive intelligence provider, The global image-guided surgery (IGS) devices market was valued...
March 05, 2025 07:00 ET | Source: FACT.MR

Bleeding Disorder Treatment Market to Reach USD 35 Billion by 2035, Growing at 7.3% CAGR | Fact.MR Report

Rockville, MD, March 05, 2025 (GLOBE NEWSWIRE) -- According to Fact.MR, a market research and competitive intelligence provider, the global bleeding disorder treatment market is estimated to reach a...
January 29, 2025 07:00 ET | Source: FACT.MR

Triple Combination Therapy Market to Surge to US$ 29.2 Billion by 2034, Growing at a 6.5% CAGR | Fact.MR Report

Rockville, MD, Jan. 29, 2025 (GLOBE NEWSWIRE) -- According to Fact.MR, a market research and competitive intelligence provider, the global triple combination therapy market reached a valuation...
January 20, 2025 07:00 ET | Source: FACT.MR

RNA Transcriptome Profiling Tests Market Expands at 14.5% CAGR, Surpassing US$ 37 Billion by 2034 | Fact.MR Report

Rockville, MD, Jan. 20, 2025 (GLOBE NEWSWIRE) -- According to Fact.MR, a market research and competitive intelligence provider, the global RNA transcriptome profiling test market is estimated to...
March 12, 2024 11:01 ET | Source: Intrommune Therapeutics

Intrommune Therapeutics Strengthens Board of Directors with Appointments of Dr. Jonathan Rich and Hem Pandya

Intrommune Therapeutics today announced the appointment of Dr. Jonathan Rich to its board of directors and Hem Pandya as Executive Chairman of the board.
February 22, 2024 09:34 ET | Source: Intrommune Therapeutics

Intrommune Therapeutics Presents Supporting Data Introducing a New Form of Food Allergy Treatment

OMIT (Oral Mucosal Immunotherapy) is a new approach to the management of food allergy demonstrating a robust immunologic response in treated subjects
February 17, 2022 00:36 ET | Source: Sunshine Care Partners

Sunshine Care Announces Final Advisory Board and General Counsel, Sets Franchising Milestones

ANNAPOLIS, Md., Feb. 17, 2022 (GLOBE NEWSWIRE) -- Sunshine Care is proud to announce its Advisory Board membership and responsibilities for each member. Sunshine Care national franchises will be...
May 17, 2019 13:25 ET | Source: Intrommune Therapeutics

Intrommune Therapeutics Receives Best Private Company Presentation Award at BioNJ’s 9th Annual BioPartnering Conference

New York, May 17, 2019 (GLOBE NEWSWIRE) -- Intrommune Therapeutics, a New York-based biotechnology company developing patient-friendly food allergy therapies for peanut and other food allergies...
March 08, 2019 10:01 ET | Source: Intrommune Therapeutics

Intrommune Therapeutics Announces Grant of European Patent Covering Oral Mucosal Immunotherapy for Food Allergy

New York, March 08, 2019 (GLOBE NEWSWIRE) -- Intrommune Therapeutics, a New York-based biotechnology company developing a patient-friendly treatment platform for peanut and other food allergies, is...
November 08, 2018 16:44 ET | Source: Intrommune Therapeutics

Intrommune Therapeutics Announces First Close of Series A Preferred Equity Financing and Successful Close of Crowdfunding Financing Campaign to Support New Peanut Allergy Treatment

New York, Nov. 08, 2018 (GLOBE NEWSWIRE) -- Intrommune Therapeutics, a New York-based biotechnology company developing a patient-friendly treatment platform for peanut and other food allergies, is...